Technical Analysis for OBIO - Orchestra BioMed Holdings, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Fell Below 50 DMA | Bearish | 2.13% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | 2.13% | |
| Down 3 Days in a Row | Weakness | 2.13% | |
| Lower Bollinger Band Touch | Weakness | 2.13% | |
| 20 DMA Resistance | Bearish | -9.43% | |
| MACD Bearish Signal Line Cross | Bearish | -9.43% | |
| NR7 | Range Contraction | -9.43% |
| Alert | Time |
|---|---|
| Down 2 % | about 20 hours ago |
| Down 1% | about 20 hours ago |
| Up 1% | about 20 hours ago |
| Lower Bollinger Band Support | about 20 hours ago |
| 1.5x Volume Pace | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Orchestra BioMed, Inc. operates as a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. It offers BackBeat Cardiac Neuromodulation Therapy (CNT), a patented, intelligent bioelectronic treatment for hypertension; Virtue SAB, a patented drug/device combination product for the treatment of artery disease; FreeHold Retractors, a minimally invasive surgical device solution; and Virtue SEB, a drug-eluting balloon angioplasty system for the treatment of coronary artery disease. Orchestra BioMed, Inc. has a strategic collaboration with Medtronic to develop BackBeat CNT as a potential treatment for hypertension in patients who are indicated for a cardiac pacemaker. The company was incorporated in 2017 and is based in New Hope, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Angioplasty Coronary Artery Disease Medtronic
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Angioplasty Coronary Artery Disease Medtronic
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.68 |
| 52 Week Low | 4.22 |
| Average Volume | 61,443 |
| 200-Day Moving Average | 6.03 |
| 50-Day Moving Average | 5.41 |
| 20-Day Moving Average | 5.81 |
| 10-Day Moving Average | 5.84 |
| Average True Range | 0.48 |
| RSI (14) | 43.82 |
| ADX | 21.85 |
| +DI | 18.94 |
| -DI | 24.00 |
| Chandelier Exit (Long, 3 ATRs) | 5.05 |
| Chandelier Exit (Short, 3 ATRs) | 6.43 |
| Upper Bollinger Bands | 6.54 |
| Lower Bollinger Band | 5.08 |
| Percent B (%b) | 0.14 |
| BandWidth | 25.18 |
| MACD Line | 0.02 |
| MACD Signal Line | 0.11 |
| MACD Histogram | -0.0892 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.61 | ||||
| Resistance 3 (R3) | 5.57 | 5.43 | 5.56 | ||
| Resistance 2 (R2) | 5.43 | 5.34 | 5.45 | 5.54 | |
| Resistance 1 (R1) | 5.35 | 5.29 | 5.39 | 5.39 | 5.52 |
| Pivot Point | 5.21 | 5.21 | 5.23 | 5.23 | 5.21 |
| Support 1 (S1) | 5.13 | 5.12 | 5.17 | 5.17 | 5.04 |
| Support 2 (S2) | 4.99 | 5.07 | 5.01 | 5.02 | |
| Support 3 (S3) | 4.91 | 4.99 | 5.01 | ||
| Support 4 (S4) | 4.95 |
